
Tutorials
ToolBox Abbreviations
Glossary
MIC419Home
webMIC419 Home
VSC519Home
Immunity Protects
Us from Infectious Disease
The Immune System Promotes Development of Immunity
Immunology Rules!
Seeing and Eliminating Antigen
Key Concepts
Immunity Protects Us from Infectious Disease.
The immune system has evolved to protect us from infectious disease. The System Module Infectious Disease describes four major groups of pathogens (disease-causing infectious agents). Antigen is the name for any molecule that stimulates an immune response. Most antigens are pathogen proteins or carbohydrates that are "foreign" or "non-self" to the host.
Even simple multi-celled animals like sea squirts and starfish, as well as many plants, have defense systems that can recognize a generic "danger" signal and respond by engulfing or walling off foreign organisms. Humans have a corresponding innate immune response that begins immediately in response to tissue damage. Phagocytes are attracted to the site of infection or tissue damage and engulf and destroy pathogens, as well as our own dead or damaged cells. In some instances, innate immune responses are effective at eliminating antigen from the body.
Innate immune responses include
Adaptive immunity is antigen-specific and found only in vertebrates. The adaptive immune system responds more quickly and efficiently to a repeat infection (immune memory), often so efficiently that no symptoms develop. A wide range of antigens can induce adaptive immunity. Adaptive immunity can be long-lasting but is not permanent. It discriminates between "self" and 'non-self", generally attacking the latter and ignoring the former. An individual's immunity depends on both environment (experience) and inheritance. Disease can result from under-activity or over-activity of the immune system. Innate immune mechanisms including inflammation and phagocytosis are essential for the efficient functioning of the adaptive immune system.
Adaptive immune responses include
Adaptive immunity is usually acquired actively by natural infection or by vaccination with killed or weakened (attenuated) pathogen or inactivated toxin (toxoid). Active immunity requires 2-3 weeks to become established and may be very long-lasting, from years to a lifetime. Adaptive immunity can also be acquired passively from an immune person by the transfer of antibodies or (rarely) immune cells. Passive immunity protects as soon as the antibodies are transferred but lasts only weeks-months as the transferred antibodies are removed from the circulation in a natural process called "turnover".
Immunity which can be transferred in serum is called humoral immunity. Examples include antibodies transferred across the placenta or in breast milk from mother to child and horse antibodies to rattlesnake venom used to treat snake bite. Immunity that can be transferred only with T cell transfer is called cellular immunity. Passive cellular immunity is limited by rejection of foreign transplanted cells, and is usually only done between inbred animals or in human bone marrow transplants where the whole blood cell-forming system is transferred.
The Immune System: Cells and Organs.
A system is a regularly interacting or interdependent group of items forming a unified whole (Merriam Webster Online Dictionary). The immune system is the collection of cells and organs that work together to provide immunity. Immune system cells, the white blood cells or leukocytes, wander the body to detect localized infections. Immune system organs provide locations where leukocytes mature and where they interact efficiently with antigen to become fully active effector cells and memory cells. Effector cells eliminate antigen, while memory cells make a more efficient response to a repeat antigen exposure.
The primary (central) immune organs are where white blood cells mature. Hematopoiesis, the development of white blood cells, occurs in the bone marrow. Pluripotent, self-renewing stem cells divide and differentiate into all types of functional blood cells. At each stage of differentiation (stem cell --> progenitor cell --> mature cell), cells become more restricted in their potential than their precursors. During hematopoiesis, lymphocytes acquire their specific antigen receptors (one specificity per cell), co-receptors required for response to antigen, cytokine receptors, and adhesion molecules that target the cells to particular immune organs. Hematopoiesis is regulated by growth factors, growth factor receptors, and programmed cell death (apoptosis). T cells complete their development in the thymus, an organ in the chest above the heart. The thymus is relatively large in infants and children when T cell development is highest. It begins to shrink at puberty, although some T cell maturation occurs throughout life. Antigen is NOT required for the development of mature antigen-specific T and B lymphocytes.
Phagocytes include two types of leukocytes : blood monocytes, called macrophages when they leave the circulation and enter the tissues, and polymorphonuclear leukocytes (PMNs or granulocytes), primarily neutrophils. A chart in the ToolBox lists the blood leukocytes and their normal values. Macrophages are large cells with round nuclei that can put out long pseudopodia to surround antigen. PMNs have lobed nuclei and many granules in their cytoplasm. Macrophages and PMNs engulf and kill pathogens, especially bacteria. Eosinophils kill parasites, especially helminths (worm parasites). Macrophages and PMNs bind common surface molecules on pathogens or antibody-coated pathogens; phagocytes are not antigen-specific and are part of innate immunity. Macrophages also produce cytokines that attract other leukocytes and make blood vessels leaky, leading to inflammation. Dendritic cells (DC) can be phagocytic under certain circumstances and, along with macrophages and B cells, are Antigen-Presenting Cells (APC) which help stimulate T cell activation.
Lymphocytes are antigen-specific leukocytes responsible for adaptive immunity. They are small, round cells with little cytoplasm and round nuclei. Lymphocytes have membrane receptors that bind antigen; each lymphocyte recognizes one specific antigen. Antigen receptor on B lymphocytes is called membrane immunoglobulin (mIg or antibody) or BCR (B Cell Receptor). Antigen receptor on T lymphocytes is called T Cell Receptor (TCR). Each lymphocyte has about 100,000 copies of its membrane antigen receptor. Lymphocytes specific for many diverse antigens are produced continually in the absence of antigen exposure. When a lymphocyte encounters its specific antigen and receives the proper costimulatory signals, it proliferates and differentiates into a clone of effector cells with the same antigen specificity. Natural Killer (NK) cells are large granular lymphocytes that lack specific antigen receptors. However, they recognize and respond to altered tissue typing (MHC) proteins present on virus-infected and cancer cells. NK cells are part of the innate immune system.
Secondary (peripheral) lymphoid organs are designed to bring together leukocytes and antigen. Peripheral lymphoid tissues are present throughout the body. Clusters of lymphocytes and specialized antigen-collecting epithelial cells called M cells line the mucous membranes of the respiratory, digestive, and urogenital systems where contact with pathogens is highest. With the tonsils, appendix, and Peyer's patches, they are called the Mucosal Associated Lymphoid Tissues (MALT). Other peripheral lymphoid organs are the spleen, where blood-borne antigens (especially bacteria) encounter the immune system, and lymph nodes, where antigens from the tissues are collected.
Fluid leaves the blood circulation at the capillaries and bathes the tissues, supplying nutrients and washing away waste products. The fluid, called lymph, then collects in the lymphatic vessels and passes through the lymph nodes on its way back to the blood circulation. If the tissues are infected, antigen is carried to the nearby (draining) lymph nodes where it comes in contact with phagocytes and lymphocytes to initiates an adaptive immune response. Lymphatic vessels transport lymph and cells from the lymph nodes back into the blood circulation. At any given time many leukocytes recirculate throughout the body and are present in high numbers in the peripheral blood circulation. Expression of adhesion molecules on endothelial cells lining the blood vessels is increased by inflammatory cytokines to signal leukocytes to enter the tissues or the secondary lymphoid organs in response to antigen.
Cells of the innate immune system are not antigen-specific; they have molecules on their membranes which bind antigens found on many infectious agents. Macrophages, PMNs, and NK cells also have membrane receptors for complexes of antibody with antigen (Fc receptors, FcR) or complement with antigen (complement receptors, CR), so that antigen which has bound antibody or complement is more easily engulfed (or, in the case of NK cells, lysed). When macrophages bind certain common bacterial antigens, they are stimulated to produce small proteins called cytokines that signal other leukocytes. Some cytokines (chemokines) are chemotactic, attracting other leukocytes to the site of infection. Other cytokines signal the blood vessel endothelial cells to express more adhesion molecules, so that leukocytes can stick and move between the endothelial cells to enter the tissues. Other cytokines increase the amount of fluid that can leave the circulation, so that antibacterial molecules enter the infection site. Some cytokines signal the bone marrow to produce more leukocytes. This whole process, which results in redness, swelling and pain at the site of infection, is called inflammation. Although not antigen-specific, inflammation is often enough to eliminate small numbers of bacterial pathogens from the body. If antigen is not eliminated, lymphocytes and antibody can also participate in inflammation during adaptive immunity.
Lymphocytes bind antigen using antigen-specific membrane proteins. The antigen receptor on B cells (BCR) is antibody. Each B cell has about 105 BCR, all with identical antigen-binding sites. Antibodies bind (are specific for) protein and non-protein antigens. BCR and soluble antibody bind antigen in its native conformation. The T cell antigen receptor (TCR) is structurally related to antibody. Each T cell has about 105 TCR which share the same antigen specificity. T cells cannot bind antigen directly to their TCR; it must first be processed (cut into peptides) and presented on (bound to) MHC molecules. Three kinds of cells are professional antigen-presenting cells (APC): macrophages, dendritic cells, and B cells. Since TCR binds processed antigen, binding does not depend on natural antigen folding; it does depend on how efficiently the antigen can be processed, bind MHC, and bind TCR. We each have a limited number of MHC molecules with which to present antigen; fortunately, each MHC can present numerous peptides to TCR.
Antigen receptors are encoded in groups of gene segments arranged linearly on the chromosome, each segment encoding part of the receptor. As B cells develop in the bone marrow and T cells develop in the thymus, they must recombine (splice together) several of these gene segments to produce a functional antigen receptor. Cells which fail to successfully produce functional receptors die without leaving the primary lymphoid organs. Recombination occurs randomly, so the millions of lymphocytes produced each day collectively have millions of different antigen specificities. The large number of different specificities that are produced is called the immune repertoire. Since receptor generation is random, cells specific for self antigens are also produced. Antigen binding to self-specific immature T and B cells in the thymus and bone marrow results in their death (clonal deletion).
Mature naïve T and B cells (those that have not yet bound foreign antigen) leave the primary lymphoid organs and recirculate through the secondary lymphoid organs. If a lymphocyte does not bind its specific antigen in a few weeks, it dies. If it does bind antigen, it proliferates into a clone of lymphocytes that differentiate into antigen-eliminating effector cells. Memory lymphocytes specific for the same antigen are also produced. This process is called clonal selection and explains the specificity of adaptive immunity. The time it takes between antigen contact and our ability to detect adaptive immunity is called the lag phase of the immune response. In a primary response to antigen, the lag phase is usually almost a week long. Detectable adaptive immunity (for example, antibody in the serum) increases for a period and then declines as antigen is eliminated. On repeat exposure (secondary response) to the same antigen, the lag period is shorter and the measurable response is higher and longer-lasting due to the clonal expansion of lymphocytes specific for that antigen during the primary response.
Antibody is a protein which serves as BCR and is also secreted to bind and remove antigen from the body. Antibody is composed of disulfide-bonded heavy and light chains in a Y shape, with two identical antigen-binding regions at the ends of the top of the Y. The antigen-binding regions of antibody differ in their amino acid sequence from one molecule to the next and are called variable regions. The stem of the Y (the constant region) has one of five possible structures (isotypes: IgA, IgD, IgE, IgG, and IgM) that determine the effector functions of the antibody.
Mature naïve (also called resting) lymphocytes must receive two signals to become fully functional effector cells. Signal 1 is always antigen: that keeps the immune response antigen-specific. B cells bind native antigen to their membrane antibody (BCR). When they receive a second cytokine or adhesion signal from helper T cells, they divide and differentiate into antibody-secreting plasma cells. T cells bind protein antigen processed (cut into peptides) and presented on (bound to) MHC molecules of Antigen-Presenting Cells (signal 1). APC can also deliver a cytokine or (usually) an adhesion signal 2 to stimulate T cell proliferation into effector cells.
Seeing and Eliminating Antigen
When the immune system functions optimally, antigen is eliminated before the host shows disease symptoms. Exogenous (extracellular) antigens, including most bacteria and their toxins, are most accessible to immune elimination. Phagocytes bind commonly shared antigens on the surface of bacteria, engulf the organisms and digest them inside phagocytic vesicles. Digestive enzymes, oxygen radicals, and peroxides released by macrophages and PMNs during inflammation kill pathogens. Complement is activated by binding to many bacterial surface molecules; once activated, it promotes phagocytosis by binding to phagocyte complement receptors. Other complement products attract leukocytes and increase blood vessel leakiness (promote inflammation) so that plasma proteins, including complement, clotting factors, and antibody, can reach the site of infection. In some cases, complement directly lyses the bacterium.
Once adaptive immunity is triggered, antibody is the primary tool for exogenous antigen elimination. B lymphocytes respond to antigen plus helper T cell signal by becoming plasma cells, which secrete antibodies. Antibodies bind to extracellular pathogens and bacterial toxins to inactivate them (neutralization). They also opsonize (coat) the pathogens to promote phagocytosis and activate complement to opsonize or lyse the pathogen and promote inflammation.
Antibodies, also called immunoglobulins (Ig), are antigen-binding proteins which are divided into five classes (isotypes) based on their structures. The amino acid sequence of antibodies differs from one molecule to the next in the antigen-binding site (variable region) but does not differ significantly in the rest of the molecule (constant region). Each isotype has different biological functions once antigen is bound, and some isotypes have more antigen-binding sites per molecule than others. IgM and IgD are antigen receptors (BCR) on B cells. Following antigen activation of B cells, IgM is the first isotype secreted. Secreted IgM is a very large molecule with 10 antigen-binding sites; it is very efficient at binding antigen and activating complement but can enter the tissues only slowly because of its size. When B cells receive helper cytokine signals from T cells, they begin secreting IgG or IgA. IgG is the predominant antibody isotype in serum; it has two antigen-binding sites and can easily enter the tissues from the circulation. IgG binding to toxins or viruses prevents them from entering cells to kill them; this is called neutralization. Following antigen binding (opsonization), IgG activates complement and IgG-antigen complexes bind FcR. Phagocytes then use both complement receptors and FcR to facilitate phagocytosis. IgA is made predominantly in mucosal lymphoid tissues. It is present in mucus secretions of the respiratory, digestive, and urogenital tracts and in breast milk. IgG and IgA neutralize virus and toxin activities by blocking host cell binding. IgE is made to helminth (worm) parasites and to environmental antigens by people who have allergies. IgE binds FcRe on mast cells, which then respond to antigen by releasing histamine.
Endogenous (intracellular) antigens, including viruses, protozoan parasites, and bacteria which survive phagocytosis, are not directly accessible to phagocytes, complement, or antibody. They must be eliminated by destruction of infected host cells. Viruses which insert their own molecules into the host cell membrane prior to using it as an envelope are somewhat more vulnerable, since antibody can bind these viral proteins and trigger complement-mediated lysis of the host cell. Antibody on phagocyte and NK cell FcR binds membrane-expressed viral antigen and trigger host cell killing (Antibody-Dependent Cell-mediated Cytotoxicity, ADCC).
For intracellular parasites which do not express their antigens on the host cell membrane, immune recognition requires antigen peptide presentation on host cell MHC and specific recognition by T cells. MHC (Major Histocompatibility Complex) proteins are plasma membrane tissue typing antigens. They were identified when immunologists began inbreeding mice to try to understand graft rejection. The primary function of MHC proteins is antigen presentation. Class I MHC molecules are present on the membranes of all nucleated cells. When these cells become infected with viruses, they can process virus proteins synthesized in their cytoplasm into peptides, combine these peptides with Class I MHC in their endoplasmic reticulum (ER), and transport the peptide-MHC complexes to their plasma membranes. Infected cells present virus peptides on their MHC Class I to the TCR of cytotoxic T cells (Tc). Tc become activated cytotoxic effector cells (CTL) that kill the infected cells (targets).
Macrophages can process and present antigen from phagocytosed pathogens on Class II MHC to helper T cells (Th1 or Th2 cells). Th1 cells signal the macrophages to fuse their lysosomes with the phagocytic vesicles and kill the intracellular pathogens more efficiently. Th2 cells secrete cytokines that signal B cells to make antibody. Both B and T lymphocytes also respond to antigen plus Th cytokines by differentiating into memory cells, which are long-lived and respond more quickly than naïve lymphocytes when re-exposed to antigen.
Some molecules on pathogens bind lymphocyte surface molecules which are not antigen receptors. If this binding induces the lymphocytes to undergo cell division (mitosis), the molecules are called mitogens. At high doses, mitogens usually induce proliferation in a high frequency of lymphocytes regardless of their antigen specificity, a process called polyclonal activation. Some mitogens are T-independent antigens, capable of inducing B cells to secrete antibody in the absence of T cell help.
Practice Quiz
Pick the one BEST answer for each question by clicking on the letter of the correct choice.
1. Central (primary) lymphoid organs
a. are efficient in exposing T cells to foreign antigen.
b. are the primary site of antibody synthesis and release.
c. filter blood and trap blood-borne antigens.
d. provide the microenvironment for maturation of T and B cells.
e. line the mucosal surfaces of the body for efficient antigen contact.
2. Hematopoietic stem cells are pluripotent, which means that they are
a. antigen-specific cells.
b. capable of developing into any blood cells.
c. committed to produce cells of a single lineage.
d. not self-renewing.
e. T and B lymphocytes of many different antigen specificities.
3. Lymphocytes continually recirculate through peripheral lymphoid tissue in order to
a. be killed before they cause autoimmunity.
b. efficiently encounter antigen.
c. mature from stem cells into lymphocytes.
d. phagocytose antigen and kill it.
e. go where no cell has gone before.
4. Peripheral lymphoid organs
a. are centrally located in the abdomen to protect their vital functions.
b. are designed to maximize contact between antigen and lymphocytes.
c. produce antigen-specific lymphocytes from stem cells in response to antigen.
d. sequester antigen to minimize its damage to the body.
e. store large numbers of activated effector cells for a rapid response to antigen.
5. The PRIMARY purpose of the adaptive immune system is to
a. block all pathogens from entering the body.
b. cure allergic reactions.
c. kill tumor cells.
d. protect from disease upon re-infection with a specific pathogen.
e. reject foreign transplants.
6. Rapid but non-antigen specific immune responses are produced by the
a. adaptive immune system.
b. innate immune system.
c. leukocytes.
d. lymphatic system.
e. memory response.
7. Vaccination protects us from infectious disease by generating memory
a. antigen.
b. lymphocytes.
c. macrophages.
d. PMNs.
e. stem cells.
8. Which situation below describes an example of innate immunity?
a. antibody production by plasma cells.
b. antigen removal by cilia in the respiratory tract.
c. complement activation by antibody bound to the surface of a bacterium.
d. memory response to influenza virus
e. recognition and killing of virus-infected cells by cytotoxic T cells.
9. The antigen specificity of an adaptive immune response is due to
a. activation of antigen-specific lymphocytes.
b. folding of antibody to fit the pathogen.
c. lysis of only certain pathogens by neutrophils.
d. phagocytosis of only certain pathogens by macrophages.
e. production of cytokines by antigen-specific macrophages
10. Clonal selection
a. begins with inflammation.
b. occurs for all leukocytes.
c. occurs in response to self antigens.
d. results in innate immunity.
e. results in proliferation of antigen-specific lymphocytes.
11. Cytokines are NOT
a. able to induce increased blood vessel permeability.
b. antigen-specific.
c. made in response to bacterial antigens.
d. signals from one cell that affects the behavior of another cell.
e. secreted by macrophages.
12. A fundamental difference between the antigen receptors on B cells (BCR) and on T cells (TCR) is their
a. different requirements for antigen presentation.
b. function following antigen binding.
c. heterogeneity from one lymphocyte to the next.
d. heterogeneity on each lymphocyte.
e. membrane location.
13. Genes for immunoglobulins (antibodies) are unlike other human genes in that
a. antibody genes are composed of introns and exons.
b. DNA for antibody molecules is inherited from only one parent.
c. gene segments must be spliced together to make each unique antibody molecule.
d. several exons encode each antibody molecule.
e. none of the above is true.
14. Humoral immunity can be acquired passively by
a. catching a virus from a friend by shaking hands.
b. receiving a vaccine of influenza virus grown in eggs.
c. receiving serum from someone who has recovered from an infection.
d. receiving leukocytes from an immune family member.
e. sharing a soda with someone who has a cold.
15. Inflammation does NOT involve
a. cytokine production by macrophages.
b. migration of leukocytes out of the circulation.
c. pain.
d. secretion of antibodies.
e. swelling at the site of infection.
16. Innate immune responses are most effective against
a. antigens resembling self antigens.
b. common antigens on bacteria.
c. genetically engineered antigens.
d. viruses.
e. viruses that have previously caused infection.
17. Lymphocytes acquire their antigen specificity
a. as they enter the tissues from the circulation.
b. before they encounter antigen.
c. depending on which antigens are present.
d. from contact with self antigen.
e. in the secondary lymphoid organs.
18. A secondary immune response is NOT
a. faster than a primary response.
b. larger than a primary response.
c. longer lasting than a primary response.
d. more likely to result in increased adaptive immunity than a primary response.
e. preceded by a longer lag period than a primary response.
19. Antibody effector functions include all of the following EXCEPT
a. activating complement on bacterial surfaces to promote phagocytosis by neutrophils.
b. binding extracellular viruses to block their entry into host cells.
c. binding intracellular viruses to initiate cytotoxicity.
d. blocking uptake of bacterial toxins by host cells.
e. coating bacteria to promote their phagocytosis by neutrophils.
20. Effector functions of complement include all of the following EXCEPT
a. attracting phagocytes to the site of infection.
b. facilitating phagocytosis of complement-coated bacteria.
c. increasing blood vessel permeability to plasma proteins.
d. lysing bacterial cells.
e. presenting antigen to B cells.
21. Jenner observed that milkmaids who were infected with cowpox were later immune to smallpox infections. This is an example of a(n)
a. acquired immunity of barrier skin cells.
b. active immunization with a non-related organism that causes similar symptoms.
c. innate immunity of milkmaids to smallpox.
d. memory response to a cross-reactive antigen.
e. passive immunization from contact with cow's milk antibodies.
22. Macrophages generally kill the bacteria they phagocytose by fusing lysosomes containing digestive enzymes with the phagocytic vesicle. In the case of pathogens which block this fusion, pathogen killing can still be achieved through the effector function of
a. B cells.
b. complement.
c. cytotoxic T cells.
d. opsonizing antibody.
e. Th1 cells.
23. Phagocytosis
a. can be stimulated by antigen binding to complement or antibody.
b. is an antigen-specific process.
c. must be preceded by antigen processing.
d. rids the body of virus-infected cells.
e. only occurs after plasma cells begin secreting antibody.
24. Several friends who went on a picnic together developed vomiting and diarrhea from eating potato salad contaminated with Staphylococcus aureus enterotoxin. Effects of the toxin could best be counteracted by
a. antibody binding and neutralization of the toxin.
b. antibody opsonization and phagocytosis of S. aureus.
c. antibody opsonization and phagocytosis of the toxin.
d. B cell binding to S. aureus.
e. cytotoxic T cell binding and lysis of S. aureus.
25. Which of the following statements is FALSE?
a. An example of passive humoral immunity is treatment with horse anti-snake venin.
b. Antigen recognized by helper T cells must be associated with Class II MHC molecules on the surface of professional APC .
c. Each lymphocyte has many antigen binding receptors, each receptor capable of binding the same antigen.
d. Recognition and killing of virus-infected cells by cytotoxic T cells is an example of adaptive immunity.
e. The innate immune system does not deal with endogenous antigen.
Organizing Immune System Information
If you like making tables to organize information, put the following individual elements in their proper places in the table below:
adenoids     antibody     appendix     B cells     basophils     bone marrow     BALT     complement     cytokines     cytotoxic T lymphocytes     dendritic cells     eosinophils    lymph nodes     lymphatic vessels     macrophages     M cells     mast cells     membrane Ig (BCR)     MHC Class I     MHC Class II     MALT     NK cells     neutrophils     Peyers Patches     plasma cells     pluripotent stem cells     progenitor cells     spleen     T cells     Th1 cells     Th2 cells    TCR     thymus     tonsils
|
THE IMMUNE
SYSTEM
|
||
|
Category
|
Name
|
Function
|
| LYMPHOID ORGANS | ||
| Central | 1. 2. |
1. B cell development 2. T cell development |
| Peripheral | 1. 2. 3. 4. 5. 6. 7. 8. 9. |
1. Antigen in tissues 2. Antigen in blood 3. Antigen in mucosal tissues 4. Antigen in mucosal tissues 5. Antigen in mucosal tissues 6. Antigen in mucosal tissues 7. Antigen in mucosal tissues 8. Antigen in mucosal tissues 9. Antigen and leukocyte transport |
| LEUKOCYTES | ||
| Granulocytes | 1. 2. 3. 4. |
1. Phagocytosis 2. Kill worm parasites. 3. Allergic reactions. 4. Unknown |
| Monocytes | 1. |
1. Phagocytosis & antigen presentation |
| Lymphocytes | 1a. 1b. 2a. 2b 2c. 3. |
1a .Extracellular
antigen recognition 1b. Antibody secretion. 2a. Presented antigen recognition. 2b. Activates B cells, MF. 2c. Kills virus-infected cells. 3. Kills virus-infected cells (innate). |
| Other cells | 1. 2. 3. 4. |
1. Antigen presentation. 2. Antigen collection (gut). 3. Develops into lymphocyte. 4. Develops into any blood cell. |
| MEMBRANE RECEPTORS | ||
| Antigen-binding | 1. 2. |
1. Binds antigen
on B cells. 2. Binds antigen on T cells. |
| Antigen-presenting | 1. 2. |
1. Presents exogenous
antigen. 2. Presents endogenous antigen. |
| SECRETED MOLECULES | ||
| Antigen-binding | 1. 2. |
1.Antigen-specific. 2.Antigen nonspecific |
| Signaling | 1. | 1. Alters cell behavior. |
Vocabulary
How do immunologists use these terms?
Complement (note spelling)
Discriminate
Naïve
Memory
Neutralization
Presentation
Professional
Recognize/see
Repertoire
Tolerance
Problem
Influenza virus infects respiratory epithelial cells. It is an enveloped virus: virus hemagglutinin (H) and neuraminidase (N) proteins, which help the virus enter and leave the host cells, are expressed on host cell plasma membranes that envelope the emerging virus particles. Influenza viruses rapidly mutate their H and N antigens, so that exposure or immunization to influenza one year does not guarantee immunity the next. "Flu shots" contain virus particles which have been grown in fertilized eggs and inactivated (killed) so they do not infect vaccine recipients. The vaccine also contains adjuvants that attract macrophages to promote virus phagocytosis. Describe the immune effector mechanisms generated by flu shots and how they prevent influenza if an immunized person is exposed.
Tutorials ToolBox MIC419Home webMIC419 Home VSC519Home
![]()